Top 50 Life Science Angel Investors (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
11 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Sahin Boydas
Angel
|
7 | United States, Mexico, Norway | Seed, Series A, Series B | Software, Financial Services, Information Technology | $125k–$150M |
|
Milad Alucozai
Angel
|
5 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Medical | $110k–$55M |
|
Jeff Dean
Angel
|
5 | United States, United Kingdom, Japan | Seed, Series A, Pre-Seed | Artificial Intelligence, Information Technology, Software | $450k–$53M |
|
bumpkins profile
Angel
|
4 | United States, Canada, India | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Robotics | $325k–$57M |
|
Nadav Rosenberg
Angel
|
4 | United Kingdom, France, Israel | Seed, Pre-Seed, Series A | Biotechnology, Artificial Intelligence, Software | $850k–$19M |
|
Jude Gomila
Angel
|
3 | United States, United Kingdom, Canada | Seed, Pre-Seed, Angel | Software, Biotechnology, Information Technology | $190k–$4.7M |
|
Stefano Bernardi
Angel
|
3 | Italy, United Kingdom, France | Seed, Pre-Seed | Software, Biotechnology, Artificial Intelligence | $100k–$45M |
|
Esther Dyson
Angel
|
3 | United States, Canada, Russian Federation | Seed, Series A | Health Care, Software, Medical | $270k–$16M |
|
Darian Shirazi
Angel
|
3 | United States, Germany, Canada | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $2M–$100M |
|
Ian Hogarth
Angel
|
3 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, E-Commerce, Artificial Intelligence | $668k–$28M |
|
Erik Peterson
Angel
|
3 | United States, Canada, Algeria | Seed, Equity Crowdfunding, Series A | Software, Biotechnology, SaaS | $69k–$20M |
|
Balaji Srinivasan
Angel
|
3 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Software | $665k–$31M |
|
Andrew Keys
Angel
|
3 | United States, India, Norway | Seed, Pre-Seed, Series A | Software, Finance, Blockchain | $1M–$34M |
|
Andrew Nutter
Angel
|
3 | France, United Kingdom, United States | Seed, Pre-Seed | Software, SaaS, FinTech | $550k–$4.9M |
|
Bradley Horowitz
Angel
|
3 | United States, United Kingdom, Germany | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $150k–$120M |
|
Kevin Moore
Angel
|
3 | United States, India, Canada | Seed, Pre-Seed, Angel | Software, Health Care, E-Commerce | $120k–$5.2M |
|
Mei Z.
Angel
|
3 | United States, United Kingdom, Singapore | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | $1M–$300M |
|
Chris Gibson
Angel
|
3 | United States, France, Switzerland | Series A, Seed | Biotechnology, Health Care, Life Science | $4.9M–$55M |
|
Mati Staniszewski
Angel
|
2 | United States | Pre-Seed | Software, Information Technology, Artificial Intelligence | |
|
Ankit Jain
Angel
|
2 | United States | Seed, Pre-Seed | Health Care, Medical, Hospital | |
|
Annie Vereecken
Angel
|
2 | Belgium | Seed, Series A | Biotechnology, Medical, Hospital | |
|
Carsten Maschmeyer
Angel
|
2 | Germany, Austria, Switzerland | Seed, Angel, Series A | Software, Information Technology, Artificial Intelligence | $99k–$22M |
|
Ed Parkinson
Angel
|
2 | United Kingdom | Seed | Software, Health Care, Life Science | $1.8M–$3.3M |
|
Patrick Collison
Angel
|
2 | United States, United Kingdom, Ireland | Series A, Seed, Series C | Software, Artificial Intelligence, Information Technology | $2.7M–$170M |
|
Sauli Törmälä
Angel
|
2 | Finland | Seed | Life Science, Biotechnology | $584k–$1.3M |
|
Nico Wittenborn
Angel
|
2 | United States, Germany, France | Seed, Series A, Series B | Software, Apps, Wellness | $1.6M–$88M |
|
Robert Kopple
Angel
|
2 | United States, United Kingdom | Convertible Note | FinTech, Finance, Life Science | |
|
Albert Wenger
Angel
|
2 | United States, Germany, Switzerland | Series A, Series B, Seed | Software, Manufacturing, Internet | $650k–$38M |
|
Nicholas Edwards
Angel
|
2 | United Kingdom | Seed | Medical, Health Care, Life Science | |
|
Luc Vauterin
Angel
|
2 | Belgium | Seed, Series A | Life Science, Data Integration, Data Visualization | |
|
Avichal Garg
Angel
|
2 | United States, Canada, Mexico | Seed, Series A | Software, Blockchain, Internet | |
|
Sam Altman
Angel
|
2 | United States, Canada, Ghana | Seed, Series A, Series B | Software, Artificial Intelligence, Internet | |
|
Jan Hammer
Angel
|
2 | China, United States, Czech Republic | Series A, Series B, Seed | Health Care, Medical, Medical Device | |
|
Sujay Jaswa
Angel
|
2 | United States, Spain, Germany | Seed, Series B, Series A | Software, FinTech, Financial Services | $1.8M–$200M |
|
Brian S. Cohen
Angel
|
2 | United States, Israel | Seed, Series A | Software, SaaS, Mobile | $300k–$12M |
|
Michael Novogratz
Angel
|
2 | United States, India, Germany | Seed, Series A | Blockchain, Cryptocurrency, FinTech | $953k–$38M |
|
Leena Niemistö
Angel
|
2 | Finland, United States | Seed, Pre-Seed | Health Care, Software, E-Commerce | $480k–$3.2M |
|
Michael Chambers
Angel
|
2 | United States | Series A | Biotechnology, Genetics, Life Science | $30M–$55M |
|
Mark Evans
Angel
|
2 | United Kingdom, United States, The Netherlands | Series A, Seed, Series C | Software, E-Commerce, Health Care | $1.4M–$24M |
|
Nat Turner
Angel
|
2 | United States, China, Colombia | Seed, Series A, Series B | Health Care, Software, Medical | $1.5M–$36M |
|
Holger Hübner
Angel
|
2 | Germany | Seed, Pre-Seed | B2B, SaaS, Audio | $177k–$987k |
|
Damien Lane
Angel
|
2 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Series A | SaaS, Software, Health Care | $459k–$16M |
|
Lars Fjeldsoe-Nielsen
Angel
|
2 | United States, Denmark, United Kingdom | Seed, Series A, Series B | Software, Information Technology, Mobile Apps | $1.8M–$150M |
|
Elad Gil
Angel
|
2 | United States, United Kingdom, Israel | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $2M–$100M |
|
Patrick Yang
Angel
|
2 | United States | Series A, Seed, Series B | Software, Health Care, Artificial Intelligence | $2.5M–$50M |
|
Ryan Bethencourt
Angel
|
2 | United States, Chile, India | Pre-Seed, Seed, Angel | Biotechnology, Food Processing, Food and Beverage | $100k–$4.6M |
|
Jon Oringer
Angel
|
2 | United States, France, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, Health Care | $175k–$56M |
|
James Hong
Angel
|
2 | United States | Seed, Series A, Angel | E-Commerce, Mobile, Internet | $100k–$25M |
|
Peter Harris
Angel
|
2 | United States | Seed | Life Science, Biotechnology, Health Diagnostics | $2.4M–$5M |
| Access all 542 angel investors in Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 61
- Round size: Seed $537k–$16M; Series A $4.1M–$50M; Series B $1.6M–$56M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
- Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Sahin Boydas is the PEF Chapter Lead of PEF Community. He previously worked at RemoteTeam.com as CEO and Founder. Sahin Boydas attended Koç University, where he took a Bachelor of Science in Computer Engineering, and Bahcesehir University, where he took a Master of Business Administration in Entrepreneurship.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Mexico, Norway
Investor stats
- Total investments: 180
- Round size: Seed $125k–$34M; Series A $6M–$35M; Series B $23M–$150M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Seezo — Seezo provides security design reviews for every feature a company builds, leveraging Gen AI to scale threat modeling. The platform helps developers ship features faster by identifying potential risks and vulnerabilities. Seezo focuses on application security (AppSec) and aims to integrate security seamlessly into the development process.
- Neurable — Neurable develops software to understand human intent by using advanced machine learning techniques to classify the electrical signals produced by your brain. Neurable's software turns these biometric signals into actionable insights for measuring emotion and providing control of connected devices.
- Reliable Robotics — Advanced automation will make aircraft safer, more available, more affordable and fundamentally transformative to the way goods and people move around the planet.
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 54
- Round size: Seed $150k–$6.7M; Pre-Seed $110k–$1.5M; Series A $13M–$55M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Japan
Investor stats
- Total investments: 93
- Round size: Seed $2.5M–$35M; Pre-Seed $450k–$3M; Series A $6.1M–$53M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
- Moonlake AI — Vibe code games and worlds into existence.
- Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Robotics
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 49
- Round size: Seed $2.3M–$9.1M; Pre-Seed $325k–$2M; Series A $10M–$57M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
- MightyFly — MightyFly is enabling worldwide access to goods with fast, on-demand delivery services for businesses and consumers. We’re putting the infrastructure in place to connect remote locations together with long range, heavy cargo aircraft. Many areas in the world today suffer from an inability to obtain critical and often urgently needed goods andsupplies at an affordable cost. Our goal at MightyFly is to solve this problem through express, customized aerial drone delivery services. MightyFly drones will transport cargo to multiple locations in a single flight across hundreds of miles of remote terrain that is difficult if not impossible to cross with trucks or other ground vehicles. We are developing vertical-takeoff-and-landing (VTOL) drones that fly more than 300 miles, and carry payloads in excess of 50 pounds at a fraction of the cost of helicopters. Featuring automated cargo loading and unloading, and requiring no launch or recovery infrastructure, MightyFly drones will accommodate ad-hoc deliveries to undeveloped sites as well as servicing locations along established routes.
- Bear Flag Robotics — Safe, productive and efficient farming operations for the next generation of growers. Customize, Orchestrate, Automate,and Scale your fleet to your needs.
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more...Investment focus
- Industry: Biotechnology, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France, Israel
Investor stats
- Total investments: 15
- Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$19M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
- thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
- Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 55
- Round size: Seed $1.4M–$4.7M; Angel $190k–$1.3M; Pre-Seed $1M–$2.8M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
- Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
- Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 17
- Round size: Seed $100k–$45M; Pre-Seed $1.4M–$2.2M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- iubenda — Make your sites & apps legally compliant across multiple languages and legislations (including the GDPR) with our lawyer-crafted, self-updating solutions.
- Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
- Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Esther Dyson - Founder @ Way to Wellville
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, Russian Federation
Investor stats
- Total investments: 72
- Round size: Seed $270k–$4.3M; Series A $1.5M–$16M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Darian Shirazi is the Managing Partner of Gradient.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 172
- Round size: Seed $2M–$10M; Series A $6.3M–$30M; Series B $22M–$100M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- SolveAI —
- Rowspace — Rowspace provides an AI platform for financial institutions to make decisions using proprietary data. The platform focuses on organizing, processing, and analyzing internal datasets alongside market information. It applies artificial intelligence and machine learning techniques tailored to financial workflows. Rowspace supports use cases such asinvestment research, risk analysis, and product strategy. The company works with financial services firms that want to operationalize data for day-to-day and strategic decisions.
- Harmattan AI — Building the Future of Autonomous Warfare.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 55
- Round size: Seed $1.5M–$8.8M; Pre-Seed $668k–$7.7M; Series A $11M–$28M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Blloc — The ultimate smartphone experience. Boost your productivity. Focus on what matters.
- Cordless — Bridging the gap between voice and text
- Heygo — Explore places to visit within the UK and around the world on Rest Less. Get inspired and plan trips to holiday destinations with us.
Erik Peterson is the Founder at DormTrader.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Seed, Equity Crowdfunding, Series A
- Geography: United States, Canada, Algeria
Investor stats
- Total investments: 60
- Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
- Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
- Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 242
- Round size: Seed $2.3M–$15M; Pre-Seed $665k–$4.2M; Series A $6M–$31M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Trepa —
- Parallax — Parallax offers a cross-border payments platform for freelancers, remote workers, and businesses. The service enables receiving international client payments, holding funds in USD, exchanging currencies, and sending money to domestic bank accounts and mobile wallets. Users manage balances and transfers through a web app with quoted rates anditemized fees. The platform supports global payouts and recurring disbursements to partners and team members. Compliance measures include identity verification and transaction monitoring aligned with regulatory standards. Documentation and support resources guide account setup, funding, and cash-out.
- Blueprint Bryan Johnson — On the surface, Blueprint may seem something about health, wellness and aging. It's really a system to make tomorrow better for you, me, the planet and our shared future with AI.
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more...Investment focus
- Industry: Software, Finance, Blockchain
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 25
- Round size: Seed $550k–$4.9M; Pre-Seed $809k–$3.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants
- Jump — Jump takes the hassle out of being a freelancer. We accompany hundreds of freelancers in their daily lives by securing their adventure. Relax, we take care of everything.
- Core Biogenesis — Biodesigning the Future of Regenerative Medicine & Skincare
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 114
- Round size: Seed $150k–$18M; Series A $5.8M–$36M; Series B $19M–$120M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- OrgOrg — OrgOrg provides internal SaaS tools for organizational productivity suite for the companies
- Odyssey — Odyssey operates as an AI start-up, provides hollywood-grade visual AI.
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, India, Canada
Investor stats
- Total investments: 99
- Round size: Seed $190k–$5.2M; Pre-Seed $120k–$3.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VantedgeAI — Fine-tuned AI models for scaling credit investing workflows, reducing analysis time and costs by up to 10x, and setting a new standard in rapid, cost-effective deal analysis and monitoring with initial focus on MBS, ABS, CLOs, etc.
- Binarly — Binarly is the world's most advanced automated firmware supply chain security platform. Using cutting-edge machine-learning techniques, Binary identifies both known and unknown vulnerabilities, misconfigurations, and malicious code in firmware and hardware components.
- SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 31
- Round size: Seed $4M–$300M; Pre-Seed $1M–$11M; Series A $17M–$155M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Coframe — Transform your website with AI-driven optimization and personalization that boosts engagement and conversions. Coframe automates growth 24/7.
- Harmonyze — Harmonyze transforms fragmented franchise operations data into clear, daily, revenue-boosting recommendations with AI-powered coaching.
- Black Forest Labs — Black Forest Labs creates advanced generative deep learning models for images and videos. They focus on making these technologies widely accessible and transparent, ensuring that their innovations are easy to use and understand. This approach aims to democratize access to cutting-edge technology and foster greater trust and utility.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 10
- Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Inato — Inato matches the right sites to the right clinical research study, globally.
- Known Medicine — Known Medicine is looking to take the experimentation of how tumors respond to cancer drugs out of the patient’s body and into the lab. The startup breaks down tumor samples into micro tumors, which they treat separately inside specialized micro-environments with different methods and see what works best.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Mati Staniszewski is the Co-Founder of ElevenLabs.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed
- Geography: United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
- Zeta Labs — Revolutionize daily tasks with our AI assistant. Not just a chatbot - it chats, understands, and performs. Free yourself to focus on meaningful things.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ankit Jain is the Founder and CEO of Infinitus Systems.
Show more...Investment focus
- Industry: Health Care, Medical, Hospital
- Stage:Seed, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Advex AI — Composer is a no-code AI vision system that enables industrial teams to train, deploy, and manage complex visual inspection tasks across manufacturing lines. Composer uses VLMs and synthetic data to achieve production performance in minutes.
- RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
- Empower Sleep — Empower Sleep provides personalized sleep care online
Annie Vereecken
Show more...Investment focus
- Industry: Biotechnology, Medical, Hospital
- Stage:Seed, Series A
- Geography: Belgium
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Angel, Series A
- Geography: Germany, Austria, Switzerland
Investor stats
- Total investments: 82
- Round size: Seed $106k–$4M; Angel $99k–$603k; Series A $1.6M–$22M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- MyGutachter — Insuretech / Legaltech / Online Service
- Articly — ARTICLY gives discerning media consumers access to high-quality content in the form of spoken-aloud audio publications. This is accomplished by selecting articles from leading German-language publishers, incorporating professional soundtracks, and making them available centrally by subscription. This helps you to stay up to date while also learningthe backstory of the top stories, despite your restricted time.
- Interior Circle — The interior circle benefit living in one every day and wanting to improve it. Others may appreciate a water supply, but we are pleased with the new vase. What if we could make only one small change while still experiencing wonderful new things This is exactly what we want to accomplish with our company! alongside youWe specifically give up ourcommission for this purpose. We utilize this money to provide housing—their own homes or other important social structures—to those living in nations with inadequate social infrastructure. Our program will not be able to alter the course of history. However, we also want to create our own business.
Ed Parkinson
Show more...Investment focus
- Industry: Software, Health Care, Life Science
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Round size: Seed $1.8M–$3.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
Patrick Collison is a CEO of Stripe.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series C
- Geography: United States, United Kingdom, Ireland
Investor stats
- Total investments: 70
- Round size: Seed $2.7M–$13M; Series A $10M–$33M; Series C $20M–$170M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Centivax — Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.
- The Interaction Company of California — The proactive AI assistant in your iMessage, WhatsApp, and more. Texts like a human, really knows you, and integrates with your life in dozens of ways.
- Enclave — Enclave is a cybersecurity startup that builds an AI‑native code‑security agent for software development and DevSecOps teams. It analyzes entire codebases to triage scanner noise and surface only the vulnerabilities that truly matter, using cross‑file taint analysis and trust‑boundary mapping. The platform helps engineering teams ship code fasterwhile reducing the risk of exploitable security issues in production. Enclave primarily targets software companies and enterprises that prioritize secure, high‑velocity development.
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Seed $584k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Nico Wittenborn is an Investor at Adjacent.
Show more...Investment focus
- Industry: Software, Apps, Wellness
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, France
Investor stats
- Total investments: 42
- Round size: Seed $1.6M–$8.5M; Series A $7.1M–$30M; Series B $7.5M–$88M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Niantic — Niantic’s mission is to use emerging technology to enrich our experiences as human beings in the physical world. We seek to build products that inspire movement, exploration, and face-to-face social interaction. Originally formed at Google in 2010, we are now an independent company with a strong group of investors including Nintendo, The PokémonCompany, and Alsop Louie Partners. We’re focused on building games that get people outside and exploring by enabling our players to have fun while visiting new places, learning about the world around them, and meeting new friends. We’ve launched Ingress, an immersive real-world mobile game played by millions of people; it's been downloaded more than 20 million times and is played in over 200 countries and territories worldwide. We've also developed Pokémon GO, which has broken records around the world and has been downloaded more than 750 million times in its first year.
- Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
- Sunnyside — Sunnyside is the #1 alcohol moderation app helping 600,000+ people drink less through tracking, coaching, and optional naltrexone via telehealth. Start your free 15-day trial.
Robert Kopple
Show more...Investment focus
- Industry: FinTech, Finance, Life Science
- Stage:Convertible Note
- Geography: United States, United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
- ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more...Investment focus
- Industry: Software, Manufacturing, Internet
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 104
- Round size: Seed $650k–$13M; Series A $1M–$38M; Series B $4.3M–$30M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- DiviGas — DiviGas is an oil and gas company that developed a new process for manufacturing membranes which has yielded vastly superior results to what a membrane can do. The company was founded in 2019 and headquartered in Central Region, Singapore.
- Carbo Culture — We are a project developer with proprietary climate technology. We are building a rapidly scalable biochar carbon removal solution.
- Marvel Fusion — Marvel Fusion is a developer of fusion energy technology used to offer environment-friendly and safe energy. Its reactor is based on the short pulse, high energy, and electrically efficient laser that is suited for commercializing baseload fusion electrical power helping consumers to access clean, safe, and reliable energy sources.The company wasfounded in 2019 and is headquartered in Munich, Bayern.
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Luc Vauterin - Board Member @ ONTOFORCE
Show more...Investment focus
- Industry: Life Science, Data Integration, Data Visualization
- Stage:Seed, Series A
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more...Investment focus
- Industry: Software, Blockchain, Internet
- Stage:Seed, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 85
- Lead/follow: no public data
Portfolio highlights
- Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
- Matic — The world's most advanced floor cleaner. Your home's best helper.
- Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.
Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator. Sam attended Stanford University.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Internet
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Ghana
Investor stats
- Total investments: 177
- Lead/follow: no public data
Portfolio highlights
- NOYACK — NOYACK builds agentic AI technology for wealth management, starting with NOYACK.ai—the first AI agent for financial literacy - and Prophit.ai , the first opensource AI agent for portfolio optimizations of ALL asset classes. The fintech platform uses autonomous AI to deliver personalized financial guidance and construct tax-optimized portfolioscombining traditional accounts (IRAs, 401(k)s, HSAs) with private market investments in venture capital, fine art, and real estate for Millennials and Gen Z investors
- Boom Supersonic — Making the World Dramatically More Accessible
- Arcadia Medicine — Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States, Czech Republic
Investor stats
- Total investments: 64
- Lead/follow: no public data
Portfolio highlights
- Sofía — Improving the way millions of people take care of their health
- Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series B, Series A
- Geography: United States, Spain, Germany
Investor stats
- Total investments: 30
- Round size: Seed $1.8M–$10M; Series A $11M–$200M; Series B $15M–$85M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Dance — Dance is an electric mobility subscription company that makes it easy to explore your city with an electric bike or moped.
- point.me — Search and book award flights and maximize the value of your points. Travel on points for less with point.me's flight award search tool.
- Varo Bank — Get access to personal banking services including no monthly fee checking, high-yield savings, cash advances up to $250 and more with Varo Bank.
Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.
Show more...Investment focus
- Industry: Software, SaaS, Mobile
- Stage:Seed, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 44
- Round size: Seed $300k–$2.5M; Series A $1.2M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
- CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
- Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, FinTech
- Stage:Seed, Series A
- Geography: United States, India, Germany
Investor stats
- Total investments: 33
- Round size: Seed $953k–$8M; Series A $11M–$38M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
- CryptoQuant — CryptoQuant is a community-driven analytics platform to lower hurdles of data-based decisions. Crypto investors often fail to make data-based decisions due to a lack of time and knowledge. We lower the hurdles of data-based decisions by saving research time and decreasing the knowledge gap.
- Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
Leena Niemistö
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Pre-Seed
- Geography: Finland, United States
Investor stats
- Total investments: 18
- Round size: Seed $480k–$3.2M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- ADESANTE — SurgeryVision is a Virtual Reality solution for Surgeons. Product is intended to be used for planning surgical procedures.
- Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.
Show more...Investment focus
- Industry: Biotechnology, Genetics, Life Science
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 3
- Round size: Series A $30M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
- Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
- 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Series A, Seed, Series C
- Geography: United Kingdom, United States, The Netherlands
Investor stats
- Total investments: 35
- Round size: Seed $1.4M–$8M; Series A $3.2M–$24M; Series C $8M–$24M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- 8fit — Get personalized workouts, custom meal plans, and nutrition guidance, right in the palm of your hand. Prioritize progress over perfection with the 8fit app!
- Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Nat Turner is based out of New York, New York, and is the CEO and Chairman of Collectors. Nat previously worked at OneOncology as a board member. Nat Turner attended the Wharton School of the University of Pennsylvania.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, China, Colombia
Investor stats
- Total investments: 75
- Round size: Seed $1.5M–$5.5M; Series A $3M–$23M; Series B $5M–$36M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
- Memora Health — Meet patients where they are. Digitize your clinical workflows to modernize and simplify patient care.
- Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Holger Hübner
Show more...Investment focus
- Industry: B2B, SaaS, Audio
- Stage:Seed, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 5
- Round size: Seed $560k–$987k; Pre-Seed $177k–$329k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.
Show more...Investment focus
- Industry: SaaS, Software, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 38
- Round size: Seed $459k–$3.1M; Pre-Seed $605k–$1M; Series A $3.2M–$16M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
- Realla — Search the entire commercial property market for offices, serviced office space, retail, industrial for sale and to rent
- IVO — Platform to allow media owners to deepen advertiser engagement, increase profitability and commercialise ad solutions with ease.
Lars Fjeldsoe-Nielsen grew up across Africa, from Angola and Guinea-Bissau to Tanzania and Libya, after his family fled the Angolan Civil War as refugees. Those early experiences instilled in him a belief that education, technology, and social innovation can transform lives and continue to anchor his career and philanthropic activities to this day.Today, Lars is a General Partner at Owl Ventures ($2.2 billion AUM), the world’s leading venture capital firm focused exclusively on education technology. He leads Owl’s expansion across Europe, Africa, and global markets, backing founders who harness AI and breakthrough technologies to make learning more accessible and impactful.Before joining Owl, Lars co-founded 2xN, an early-stage fund at the frontier of deeptech and quantum innovation, with standout investments including Quantinuum (valued above $10 billion), Oxford Ionics (acquired by IonQ in a $1 billion deal), QSimulate, and Sparrow Quantum. Prior to that, he was a General Partner at Balderton Capital in London during which time the firm led the Seed and Series A rounds in Revolut. His investments also span education (Labster, uLesson, StudySmarter, Kukua), mobility (Yassir, Voi, Monta, NoTraffic), and mobile and frontier tech (Hiya, Monarch Money, Rahko, Pocket, Colossal, Celus, Octant Bio, Vivino, OpenSea, Blue Bottle Coffee).Lars previously spent a decade in Silicon Valley, shaping some of tech’s most iconic growth stories. At Uber, he joined when it operated in fewer than 20 cities and, as Vice President, forged global alliances with Verizon and América Móvil that fueled its international expansion. Before Uber, as Head of Mobile at Dropbox, he was among the first 25 employees and helped the company reach its first 100 million users through partnerships with Samsung and other OEMs.Despite his career in technology and venture capital, Africa has never left Lars’s journey. After his father’s passing, he returned to Angola to trace his family’s history, discovering that his sister had died of malaria as a child. That revelation transformed a personal loss into a mission. A technologist turned humanitarian innovator, Lars filed a patent for genetically modified mosquitoes that light up when carrying malaria and began funding malaria-research projects in Angola through partnerships with global nonprofits. In 2024, he climbed Mount Kilimanjaro to raise funds for malaria research, following earlier campaigns such as climbing the Matterhorn and crossing the Sahara by motorbike.A Danish-Portuguese national who served with the Royal Danish Guards, Lars holds an MBA from London Business School, where he was a member of the Board of Governors and Chairman of the Endowment Fund, an MSc from Oxford University (Keble College), and a BSc from King’s College London. Across every chapter, from refugee to technologist to investor, his purpose endures: advancing education, health, and innovation as catalysts for social change.
Show more...Investment focus
- Industry: Software, Information Technology, Mobile Apps
- Stage:Seed, Series A, Series B
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 71
- Round size: Seed $1.8M–$10M; Series A $4M–$48M; Series B $9.6M–$150M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Tajir — Tajir offers full transparency on the prices of various products, addressing a challenge that store owners confront offline each day, and sells and delivers inventories to the stores, said the Khan brothers, whose father ran an FMCG retail distribution business for three decades.
- StudySmarter — StudySmarter is an EdTech company that develops an intelligent and content-agnostic platform for lifelong learning. It was first published in 2018 and is used by millions of learners worldwide. StudySmarter has been voted the best EdTech start-up in Germany and Europe by university representatives and education experts.
- Empirical — Culinary & scientific innovations applied in flavor to spirits and cans. From premium spirits to ready to drink cans, Empirical has an exciting selection. Order today!
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 239
- Round size: Seed $2M–$15M; Series A $9.5M–$50M; Series B $28M–$100M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Petual — Petual is building the AI-powered platform for audit and compliance, transforming how enterprises manage SOX, operational, financial, and compliance risk. Our intelligent agents deliver precision, coverage, and speed impossible with manual testing.
- Harvey — Harvey is an artificial intelligence technology service provider.
- BuildForever — BuildForever build products that feel personal, magical and deeply human.
Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States
Investor stats
- Total investments: 33
- Round size: Seed $2.5M–$4.5M; Series A $5M–$16M; Series B $35M–$50M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
- Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.
Show more...Investment focus
- Industry: Biotechnology, Food Processing, Food and Beverage
- Stage:Pre-Seed, Seed, Angel
- Geography: United States, Chile, India
Investor stats
- Total investments: 16
- Round size: Seed $100k–$4.6M; Pre-Seed $100k–$945k
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Evo Foods — EVO foods is creating India’s first 100% plant based liquid egg
- WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
- Arcturus BioCloud — Arcturus delivers granular insights, climate metrics and sustainability risks on the drivers of climate and ESG profiles for investment holdings via a climate and Sustainability Intelligence SaaS.
Jon Oringer is the founder and chairman of Shutterstock.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 115
- Round size: Seed $375k–$5.5M; Pre-Seed $175k–$2.5M; Series A $4M–$56M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
- Gently — Find secondhand clothing, effortlessly. Wearloom sends you the best new listings from sites like Poshmark, Depop, eBay, ThredUp, and Vestiaire Collective.
- Zamp — The last sales tax service you'll ever need. We take care of everything: registrations, filings, notices, and support.
James Hong
Show more...Investment focus
- Industry: E-Commerce, Mobile, Internet
- Stage:Seed, Series A, Angel
- Geography: United States
Investor stats
- Total investments: 29
- Round size: Seed $100k–$3.7M; Angel $975k–$3M; Series A $1M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
- Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
- Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Peter Harris
Show more...Investment focus
- Industry: Life Science, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $2.4M–$5M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- CND Life Sciences — CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
Life Science Angel investor funding at a glance
Stats across 413 deals from 542 investors.
Access all 542 angel investors in Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 542 angel investors investing in Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!